Table 5 The total number of patients with pain breakthrough episodes during the study period and during day 4, i.e. the day of CEA removal, and the number of patients receiving extra doses of opiates during day 4.
Group B | Group R | P value | |
|---|---|---|---|
Patients with pain breakthrough episodes total/n | 40/66 | 43/69 | 0.49 |
Patients with pain breakthrough episodes day 4/n | 25/66 | 17/68 | 0.08 |
Patients receiving extra doses of opiates day 4/n | 54/66 | 55/68 | 0.89 |